These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26059887)

  • 1. Lack of harmonisation in the classification of renal impairment in European Summaries of Product Characteristics.
    Salgado TM; Arguello B; Martinez-Martinez F; Benrimoj SI; Fernandez-Llimos F
    Intern Med J; 2015 Jun; 45(6):686-7. PubMed ID: 26059887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strategies of age-adapted pharmacotherapy in renal failure].
    Lenssen R; Liekweg A
    Z Gerontol Geriatr; 2016 Aug; 49(6):494-9. PubMed ID: 27447457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart and kidneys--a fatal relationship].
    Solík P; Gonçalvesová E
    Vnitr Lek; 2010 Sep; 56(9 Suppl):988-94. PubMed ID: 21137172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic therapy in renal insufficiency].
    Legallicier B; Le Roy F; Fillastre JP
    Presse Med; 1997 Nov; 26(37):1820-5. PubMed ID: 9569904
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversy: is there a "renal dose" dopamine?
    Vovan T; Brenner M
    Crit Care Med; 2000 Apr; 28(4):1220. PubMed ID: 10809310
    [No Abstract]   [Full Text] [Related]  

  • 7. [New recommendations for antibiotic dosing in patients with renal insufficiency and in patients undergoing haemodialysis].
    Moser C; Elung-Jensen T; Høiby N
    Ugeskr Laeger; 2008 Feb; 170(8):629-32. PubMed ID: 18364153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualization of drug therapy in renal or liver insufficiency].
    Martin-Facklam M
    Ther Umsch; 2000 Sep; 57(9):568-72. PubMed ID: 11036437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
    Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the antidiuretic response of kidneys to different modes of vasopressin administration].
    Grigor'ev AI; Larina IM; Buravkova LB; Goncharova AG; Dobrokhotov IV; Natochin IuV
    Fiziol Cheloveka; 2003; 29(3):89-97. PubMed ID: 12845788
    [No Abstract]   [Full Text] [Related]  

  • 13. High tobramycin serum concentrations after tobramycin inhalation in a child with renal failure.
    de Velde F; Emonts M; Verbruggen S; van der Sijs H
    J Antimicrob Chemother; 2014 Nov; 69(11):3163-4. PubMed ID: 25006239
    [No Abstract]   [Full Text] [Related]  

  • 14. Albuminuria as a surrogate marker for drug development: a European Regulatory perspective.
    Calvo G; de Andres-Trelles F
    Kidney Int Suppl; 2004 Nov; (92):S126-7. PubMed ID: 15485407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-on-chronic liver failure: the kidneys.
    Cárdenas A; Ginès P
    Curr Opin Crit Care; 2011 Apr; 17(2):184-9. PubMed ID: 21311322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The codes for chronic kidney disease. Help in distinguishing between renal failure and renal insufficiency.
    Gold RS; Bowman S
    J AHIMA; 2006 Jan; 77(1):76-8. PubMed ID: 16475746
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterizing the impact of renal impairment on the clinical pharmacology of biologics.
    Meibohm B; Zhou H
    J Clin Pharmacol; 2012 Jan; 52(1 Suppl):54S-62S. PubMed ID: 22232754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose baclofen treatment-induced overdose in a chronic ethylic patient with renal insufficiency].
    Gégu C; Gagnon N; Schmitt C; Tichadou L; Hayek-Lanthois M; De Haro L
    Therapie; 2012; 67(6):529-31. PubMed ID: 23249579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renal insufficiency due to interstitial nephritis in sarcoidosis].
    Vasil'ev VI; Sedyshev SKh; Radenska-Lopovok SG; Logvinenko OA; Simonova MV; Aleksandrova EN; Safonova TN; Fadienko GR; Varlamova EIu; Nasonov EL
    Ter Arkh; 2009; 81(12):67-71. PubMed ID: 20481054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and novel pharmacological approaches to renal insufficiency in heart failure.
    Hindnavis V; Tang WH
    Minerva Cardioangiol; 2006 Dec; 54(6):753-62. PubMed ID: 17167387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.